Noah Medical is a medical technology company that develops robotic-assisted platforms for bronchoscopic procedures. Its Galaxy System is designed to help pulmonologists and other clinicians navigate the lungs and obtain tissue samples for diagnosing suspected lung cancer and other pulmonary conditions.
Subscribe to see Noah Medical’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
Noah Medical is a medical devices company headquartered in United States. Its most recent funding round, Series B, raised $150M in April 2023. Xcout recorded 18 job postings from Noah Medical in the last 90 days.
Every round on record:
| Date | Round | Amount | Investors |
|---|---|---|---|
| Series B | $150M | 11 named |
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
Xcout recorded 18 job postings from Noah Medical in the last 90 days, from a hiring record Xcout has kept since August 2026.
The weekly hiring trend, the roles and locations behind it — see Noah Medical's hiring signals →
A few of Noah Medical's closest competitors — see the full list of competitors and alternatives →
Broncus Holding Corporation is a global medical technology company specializing in the development of interventional pulmonology products. Its market reach extends across Mainland China, the European Union, the United States, and other international territories. The company's innovative product lineup includes advanced navigation systems such as LungPoint Virtual Bronchoscopic Navigation, a sophisticated computer-assisted image-based software solution. It also offers LungPoint Plus, a system providing real-time airway guidance crucial for lung biopsies and other medical interventions, and LungPro, a virtual bronchoscopic navigation product that enables three-dimensional real-time guided transbronchial needle aspiration alongside proprietary parenchymal navigation. Beyond navigation, Broncus provides a suite of therapeutic products. These feature InterVapor, a targeted bronchoscopic thermal vapor ablation system designed to treat diseased, hyper-inflated lung segments. Additionally, it offers an RF Generator paired with an RF Ablation Catheter, forming a radiofrequency ablation system specifically developed to target lung cancer. The H-Marker, a pulmonary surgical marker, is another key offering. The company further supplies a range of specialized procedural devices, including the BioStarNeedle, a single-use ultrasound-guided aspiration needle for retrieving tissue samples, and the FleXNeedle, a versatile multipurpose biopsy needle. Complementing these are various bronchoscopic accessories like the Archimedes Sheath, a sterile, single-use flexible tube that serves as a working channel during bronchoscopic procedures. The Archimedes Dilation Balloon, another sterile, single-use flexible tube with a distal balloon, is used to dilate target lung tissue within the bronchial tree after insertion through a bronchoscope or sheath. Finally, the Steerable Sheath provides a steerable adjustment handle and an additional working channel. Broncus Holding Corporation was established in 2012 and maintains its corporate headquarters in Hangzhou, China.
Founded in 2019 and headquartered in Shanghai, China, Ronovo Surgical is a medical technology company focused on developing digital and robotic surgical systems to address unmet clinical needs.
Distalmotion develops and manufactures the DEXTER Robotic Surgery System, a medical device designed to simplify minimally invasive procedures for surgeons and hospitals. The system integrates into existing operating room workflows, enabling healthcare facilities to expand patient access to robotic-assisted surgery.
Robocath is a French medical technology company based in Rouen that designs and develops robotic solutions for cardiovascular treatments. Its flagship product is the R-One+ system, which assists cardiologists in performing robotic procedures.
3DBiopsy, Inc. operates as a medical device company that develops 3D mapping software, biopsy needles, biopsy actuators, and integrated pathology systems.
CSA Medical Inc is a medical device company that develops the RejuvenAir System, a cryosurgical device designed to treat chronic bronchitis and chronic obstructive pulmonary disease (COPD). The system uses liquid nitrogen spray in a minimally invasive procedure to destroy diseased cells in the airways, allowing healthy cells to regenerate.
Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.
Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →
Post the link and the card appears automatically — each network fetches the image itself.